| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
CareSource
| Facility | $7,279.93 | $31,849.69 | $62,999.37 | |
CareSource
| Professional | $52,499.48 | $57,749.43 | $74,999.25 |
Oncology, chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs), from cultured CSCs and primary tumor cells, categorical drug response reported based on percent of cytotoxicity observed, a minimum of 14 drugs or drug combinations
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
CareSource
| Facility | $7,279.93 | $31,849.69 | $62,999.37 | |
CareSource
| Professional | $52,499.48 | $57,749.43 | $74,999.25 |